Prophylactic thyroidectomy in medullary thyroid cancer

被引:0
|
作者
Peix, Jean-Louis [1 ]
Lifante, Jean Christophe [1 ]
Chazot, Francoise Borson [1 ]
Giraud, Sophie [1 ]
机构
[1] Ctr Hosp Lyon Sud, F-69495 Pierre Benite, France
来源
关键词
CARCINOMA MEDULLARY; THYROID NEOPLASMS/SURGERY; GENETIC DISEASES INBORN; ENDOCRINE NEOPLASIA TYPE-2; RET PROTOONCOGENE; MALIGNANT PROGRESSION; GENE CARRIERS; CARCINOMA; MUTATION; GUIDELINES; PHENOTYPE; MEN; SURGERY;
D O I
10.1016/S0001-4079(19)31708-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medullary thyroid cancer (MTC) is genetically determined in 30 % to 35 % of cases, notably through multiple mutations in the RET protooncogene located on chromosome 10, for which a genotype-phenotype relationship determines age of onset. There are three phenotypes: MEN 2 A and B, and isolated familial MTC The type of mutation determines 3 levels of aggressiveness. Current guidelines recommend thyroidectomy during the first months of life for patients with very-high-risk (level 3) mutations and before 5 years of age for high-risk (level 2) mutations. There are no precise recommendations for lower-risk mutations, for which the surgical decision also depends on the calcitonin level and family history We describe 18 patients who underwent prophylactic surgery. Regardless of the mutation, all patients with a normal preoperative cakitonin level were cured. However, surgery was performed later than recommended, for various reasons, including late genetic diagnosis and parents' opposition.
引用
收藏
页码:1247 / 1258
页数:12
相关论文
共 50 条
  • [41] Vandetanib In Medullary Thyroid Cancer
    Frampton, James E.
    DRUGS, 2012, 72 (10) : 1423 - 1436
  • [42] Update on Medullary Thyroid Cancer
    Hu, Mimi I.
    Ying, Anita K.
    Jimenez, Camilo
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (02) : 423 - +
  • [43] MEDULLARY-THYROID CANCER
    MOLEY, JF
    SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (03) : 405 - 420
  • [44] MEDULLARY-THYROID CANCER
    CALMETTES, C
    BULLETIN DU CANCER, 1990, 77 (11) : 1063 - 1072
  • [45] A Benign Medullary Thyroid Cancer
    Pishdad, Reza
    Rad, Mona Vahidi
    Cespedes, Lissette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [46] Management of medullary thyroid cancer
    Ball, D. W.
    MINERVA ENDOCRINOLOGICA, 2011, 36 (01) : 87 - 98
  • [47] Medullary thyroid cancer: an introduction
    Gupta, M. K.
    CURRENT ONCOLOGY, 2019, 26 (05) : 294 - 294
  • [48] Management of Medullary Thyroid Cancer
    Viola, David
    Elisei, Rossella
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 285 - +
  • [49] Hereditary medullary thyroid cancer
    Fendrich, V.
    Zahn, A.
    CHIRURGIE, 2023, 94 (05): : 393 - 399
  • [50] MEDULLARY-THYROID CANCER
    CALMETTES, C
    M S-MEDECINE SCIENCES, 1991, 7 (01): : 22 - 29